Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer
about
Molecular markers for colorectal cancer screeningGenetics and Genetic Biomarkers in Sporadic Colorectal CancerDiscovery and Validation of Hypermethylated Markers for Colorectal CancerIntegrated genomic analysis of colorectal cancer progression reveals activation of EGFR through demethylation of the EREG promoterMethylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus.Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use.Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis.Epigenetic Silencing of MORT Is an Early Event in Cancer and Is Associated with Luminal, Receptor Positive Breast Tumor Subtypes.Levels of human replication factor C4, a clamp loader, correlate with tumor progression and predict the prognosis for colorectal cancer.Advanced colorectal adenoma related gene expression signature may predict prognostic for colorectal cancer patients with adenoma-carcinoma sequence.Comprehensive DNA Methylation Analysis Reveals a Common Ten-Gene Methylation Signature in Colorectal Adenomas and Carcinomas.DNA hypermethylation appears early and shows increased frequency with dysplasia in Lynch syndrome-associated colorectal adenomas and carcinomas.Epigenetics override pro-inflammatory PTGS transcriptomic signature towards selective hyperactivation of PGE2 in colorectal cancerDNMT1-associated long non-coding RNAs regulate global gene expression and DNA methylation in colon cancer.Development and Application of a Microfluidics-Based Panel in the Basal/Luminal Transcriptional Characterization of Archival Bladder CancersGenome-wide methylation analysis identifies a core set of hypermethylated genes in CIMP-H colorectal cancer.Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathwayThe molecular pathogenesis of colorectal cancer and its potential application to colorectal cancer screeningDifferential DNA methylation patterns of homeobox genes in proximal and distal colon epithelial cells.DNA Hypomethylation Contributes to Genomic Instability and Intestinal Cancer Initiation.TP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumorsAberrant DNA methylation of WNT pathway genes in the development and progression of CIMP-negative colorectal cancerSEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.Integrated analysis of genome-wide DNA methylation and gene expression profiles identifies potential novel biomarkers of rectal cancer.LINE-1 is preferentially hypomethylated within adenomatous polyps in the presence of synchronous colorectal cancer.Aberrant methylation patterns in colorectal cancer: a meta-analysis.Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.Mutational dynamics between primary and relapse neuroblastomas.Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.Evolution of Premalignant Disease.New insights into the earliest stages of colorectal tumorigenesis.Molecular genetic changes in benign colorectal tumors synchronous with microsatellite unstable carcinomas do not support a field defectIdentification of novel methylated targets in colorectal cancer by microarray analysis and construction of co-expression network.Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies.Discovery of methylated circulating DNA biomarkers for comprehensive non-invasive monitoring of treatment response in metastatic colorectal cancer.Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.Colorectal cancer prevention: Immune modulation taking the stage.Molecular characterization of colorectal adenomas with and without malignancy reveals distinguishing genome, transcriptome and methylome alterations.A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
P2860
Q27010063-BEAA314A-A273-44D2-9093-E6B46AB98489Q28084346-10833DF0-5C8A-440F-8A7E-0B103343EDDAQ28277670-1CD6C12E-2E6E-4AED-8DB9-524C9B229AEBQ30276647-3210A8F5-BBDF-49F2-9074-4D4C2642371DQ30685917-98A54D10-B68C-4D83-8137-28B648FF0A86Q30826635-4E460DA3-A9B0-441E-972E-E1D10972273DQ34196315-81999B82-637C-4FB0-9405-1ED2FC27EF5CQ34558559-0C72EC56-3DED-400A-953F-46EDD41FD46CQ34636473-2146F755-1C0A-42DD-A8A4-5F1070C07DABQ34671136-60DBA251-2575-46B2-87B3-E22E7F822611Q35751045-5FE1DFAE-38B3-42DF-B578-94079B5784A1Q35878544-20B6014C-CC35-4F2D-BE3B-CF3E4F9CF142Q35881186-6FBAB418-81C4-4885-B2AB-48BE1480AA4BQ36142411-4E79B58F-4528-423D-B6EC-6BEA3013185FQ36192868-AD289EB3-2A55-44D8-97AF-4787FD898CECQ36325939-CAC11959-1B54-4250-A583-AC6F37C54A3CQ36533260-CC614F22-FD2E-42F0-8387-3602EBA157D6Q36656549-8A2FC41C-7524-40AD-AFC0-971E1663058EQ36775698-391BE136-C002-482B-9831-EA79FAF676D8Q37059820-B86D31CB-12FC-46E9-95CE-FE27967BDBC1Q37142410-EB3D96AA-F387-4C52-935B-3CAF19E070CEQ37187454-13EFA88C-2D26-43A9-B417-4A68EC89DC76Q37267725-1782A5FE-4AB4-4B5A-969B-0800D35C3F84Q37641812-53820088-3B7B-4DA6-AD51-0CB8CEF14801Q37692550-41C9CBBC-87DB-44E6-8C49-7DE8A42248C2Q37706504-F3F8DC7A-9875-444A-A0EB-7AA2D9E6AA5FQ37729102-71AA61FE-FA57-473D-85E6-037B391BA1EAQ38859077-454EB20D-BCCC-4CB3-88DF-AD4ECAE7DFDDQ39037160-54780A39-79A6-4498-8182-243EF02A66D2Q39296522-D95E30AE-5B26-4DCF-83C6-27BD06C95329Q39306327-BF948BA3-5CF7-41A4-A305-68EE58EC8EFCQ40955399-B21FDE32-25F8-44F7-9B37-FDD764890D6DQ41611653-30B853A0-6AA5-4FC9-AE00-DC324969F098Q42379227-BA130029-3DEF-4D7C-858C-A1FB6ABC024AQ43185856-C718C56B-C8E0-4E8F-A4D4-91FC3993D3EAQ46213853-0A9D56FC-4D41-41E2-935E-B6BC6A6D258EQ48017354-12743C9D-CBD6-4707-BCF2-230537E02769Q49391998-1C0A2352-D59F-4C7F-9A35-C8B9CD334292Q49912428-CCEECE84-C5EF-41BD-B226-B4A830DEF73FQ52568288-8F111554-0DE8-4E51-99A8-9CD97BB34014
P2860
Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Differences in DNA methylation ...... m adenoma to colorectal cancer
@ast
Differences in DNA methylation ...... m adenoma to colorectal cancer
@en
Differences in DNA methylation ...... m adenoma to colorectal cancer
@nl
type
label
Differences in DNA methylation ...... m adenoma to colorectal cancer
@ast
Differences in DNA methylation ...... m adenoma to colorectal cancer
@en
Differences in DNA methylation ...... m adenoma to colorectal cancer
@nl
prefLabel
Differences in DNA methylation ...... m adenoma to colorectal cancer
@ast
Differences in DNA methylation ...... m adenoma to colorectal cancer
@en
Differences in DNA methylation ...... m adenoma to colorectal cancer
@nl
P2093
P2860
P3181
P1433
P1476
Differences in DNA methylation ...... m adenoma to colorectal cancer
@en
P2093
Andrew M Kaz
Chao-Jen Wong
Cornelia M Ulrich
James D Lutterbaugh
Jianping Wang
Joseph E Willis
Karen W Makar
Kelly T Carter
Sanford D Markowitz
Shelli M Morris
P2860
P304
P3181
P356
10.1053/J.GASTRO.2014.04.039
P407
P577
2014-04-30T00:00:00Z